Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
about
Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer.Investigation of anti-infection mechanism of lactoferricin and splunc-1.Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine.In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes.Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.Treatment of acute lymphoblastic leukemia from traditional chinese medicineComputational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine.In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancersEvaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation.In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndromeDrug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine.Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptorIn silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.In silico investigation of potential pyruvate kinase M2 regulators from traditional Chinese medicine against cancers.Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancerInvestigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.Multitargeted bioactive ligands for PPARs discovered in the last decade.Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?A possible solution for hair loss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine.
P2860
Q30366183-6FC9E696-4514-4474-8E32-252182734701Q30422493-625BEEDE-4666-4B52-8296-A6A1D99854BEQ30657668-3E7AF0B0-70D5-4EA9-B739-1CBE450C0E9AQ33608964-49D73114-0E61-49C6-B347-0C4F1FA3C535Q33614360-779B483F-92BF-4F29-B236-F79986DAAE12Q33614602-E5CF7D9B-0556-4B93-97C8-90325601AA8BQ33614632-77455CA3-741A-4AB2-9D67-089738EF7567Q33661003-58682532-56FB-4936-8AD1-16D10D54AE62Q33666808-33A91213-608F-49E0-9F39-9D131F63787BQ33668052-E502660D-25FF-465D-AFA4-18EA4690FF31Q33668408-C90CFDE4-E7BE-4FF9-BA79-DFC289B93BC1Q33736326-32645BCC-3242-49D8-B978-A3169DE04BE1Q33746550-673B9038-6DA1-4517-947F-5DF0FFD96266Q33747644-E55AAE47-BC9D-4B56-946B-AC47D522CCCAQ33757779-5DEDE345-C21B-4853-B147-2FA056749A3AQ33790946-66452CC0-8D22-4B39-8956-D0DD3BCC8507Q33821712-460722F2-60D4-4695-9BF3-02833797533EQ33876312-197BA61D-9878-45DF-AECF-A87F89BC0489Q33876519-CB44F59D-7420-4C8E-B56A-7C6C6BC960B5Q33876600-1A03AA42-1974-45B5-AB25-C42CD4D3F3C0Q33893880-01426E2B-9B9E-498E-BEBE-94CDB5425B7BQ33895166-56343BF0-979D-459A-9211-AFD6809E63CAQ34022289-AD48ADF7-35D0-4842-9193-F5C61727BDE5Q35137889-B0591CB6-33F1-4B33-A31F-973BB70A7F77Q37556518-BC460A54-68E6-44C2-9F70-5F0A8E7A3AFFQ38273378-BD505F3F-604F-4155-95B9-1225EFC5D504Q38869029-5348C76A-C1B3-48BF-B01B-F14484C2BCACQ44806080-2C06EE12-A1EC-490F-908D-4F5F133264DFQ47724399-91897D09-B216-4EEC-9E07-6E46FBE84C06
P2860
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@ast
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@en
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@nl
type
label
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@ast
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@en
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@nl
prefLabel
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@ast
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@en
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.
@nl
P2093
P2860
P1476
Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine
@en
P2093
Calvin Yu-Chian Chen
Hung-Jin Huang
Kuan-Chung Chen
Su-Sen Chang
P2860
P304
P356
10.1080/07391102.2012.689699
P577
2012-06-26T00:00:00Z